Showing 5221-5230 of 5621 results for "".
- Precision Medicine to Prevent Glaucoma-Related Blindnesshttps://modernod.com/news/precision-medicine-to-prevent-glaucoma-related-blindness/2476617/Approximately 10% of patients become blind despite using evidence-based guidelines developed from clinical trials and epidemiology studies. Our purpose is to review opportunities to decrease glaucoma-related blindness using the emerging principles of precision medicine.
- Central Retinal Vein Occlusion Rarely Complicates Ulcerative Colitishttps://modernod.com/news/central-retinal-vein-occlusion-rarely-complicates-ulcerative-colitis/2476609/Central retinal vein occlusion (CRVO) can rarely complicate the course of inflammatory bowel disease (IBD), according to a case series, as reported by Reuters. As many as 11.8% of patients with IBD can develop ophthalmological compl
- RAZ Mobility Launches Accessible Mobile Phone for Individuals with Impaired Visionhttps://modernod.com/news/raz-mobility-launches-accessible-mobile-phone-for-individuals-with-impaired-vision/2476607/RAZ Mobility has announced the launch of the Lucia, a mobile phone specifically designed to address the unique needs of people who are blind, low vision, or hard of hearing. Someone who is completely blind can use Lucia just as fully and effectively as someone who is sighted. According to
- Biophytis Files Registration Statement for Proposed Initial Public Offering in the United Stateshttps://modernod.com/news/biophytis-files-registration-statement-for-proposed-initial-public-offering-in-the-united-states/2476604/Biophytis announced that it has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) in relation to a proposed initial public offering of American Depositary Shares representing ordinary shares of Biophytis. Biophytis has applied to list its shares
- Ocular Therapeutix OTX-TP Intracanalicular Insert Fails to Meet Phase 3 Endpointhttps://modernod.com/news/ocular-therapeutix-otx-tp-intracanalicular-insert-fails-to-meet-phase-3-endpoint/2476598/Ocular Therapeutix’s intracanalicular insert failed to meet its primary endpoint of statistically significant superiority in mean reduction of IOP compared with placebo at all nine time points, according to a company news release. OTX-TP is an intracanalicular insert that delivers a
- Alcon Reports First Quarter 2019 Trading Updatehttps://modernod.com/news/alcon-reports-first-quarter-2019-trading-update/2476592/Alcon reported selected financial results for the first quarter ending March 31, 2019, and provided financial guidance for the current fiscal year. For the first quarter of 2019, worldwide net sales were $1.8 billion, flat on a reported basis and an increase of 4 percent on a constant currency ba
- Patients Equally Pleased With Different Keratoplasty Approacheshttps://modernod.com/news/patients-equally-pleased-with-different-keratoplasty-approaches/2476586/Although the Descemet Endothelial Thickness Comparison Trial (DETECT) showed better visual acuity with a newer, more demanding corneal transplantation method, this did not translate into greater patient satisfaction, according to a secondary analysis of outcome data, as
- Colorlite Colorblind Diagnostic and Correction System Now Available in the United Stateshttps://modernod.com/news/colorlite-colorblind-diagnostic-and-correction-system-now-available-in-the-united-states/2476585/The Colorlite Colorblind Diagnostic and Correction System, which has been used in Europe for more than 20 years, is now available in the United States, according to a company news release. </
- Allegro Announces Positive Results of Ex-US Proof-of-Concept Trial With ALG-1007 for Dry Eye Diseasehttps://modernod.com/news/allegro-ophthalmics-announces-positive-results-of-ex-us-proof-of-concept-trial-with-integrin-inhibitor-alg-1007-for-dry-eye-disease/2476583/Allegro Ophthalmics announced positive results of an ex-US proof-of-concept clinical trial of the new investigational ALG-1007 topical drop drug candidate in patients with dry eye disease (DED). The results were presented by Eric D. Donnenfeld, MD, last week at the 2019 American Society of Catara
- PECAA Launches the Integrated Eye Care Initiativehttps://modernod.com/news/pecaa-launches-the-integrated-eye-care-initiative/2476579/PECAA, a nationwide doctor alliance group for independent eye care professionals, has launched a new program, the “Integrated Eye Care Initiative,” which is aimed at driving informed decision making for th